Pmv Pharmaceuticals

Price & Volume

Stats

Open	$1.63
Previous Close	$1.64
Day Range	$1.63-$1.66
52W Range	$1.40-$3.47
Market Cap	$83.9M
Shares Short	975,907

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$0.96

News

Yahoo Finance • 12 months ago

PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights

Yahoo Finance • last year

PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation

Yahoo Finance • last year

PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar

Yahoo Finance • last year

PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

About

CEO	Dr. David H. Mack Ph.D.
Address	1 Research Way, Princeton, NJ, United States, 08540
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	63